{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:32:44Z","timestamp":1793057564544,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"vor","delay-in-days":1461,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2014]]},"DOI":"10.1038\/ki.2013.335","type":"journal-article","created":{"date-parts":[[2013,9,11]],"date-time":"2013-09-11T12:39:25Z","timestamp":1378903165000},"page":"416-424","source":"Crossref","is-referenced-by-count":55,"title":["Hereditary features, treatment, and prognosis of the lipoprotein glomerulopathy in patients with the APOE Kyoto mutation"],"prefix":"10.1016","volume":"85","author":[{"given":"Zhangxue","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songmin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziying","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sizhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2013.335_bb0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0272-6386(89)80134-9","article-title":"Lipoprotein glomerulopathy: glomerular lipoprotein thrombi in a patient with hyperlipoproteinemia","volume":"13","author":"Saito","year":"1989","journal-title":"Am. J. Kidney Dis."},{"key":"10.1038\/ki.2013.335_bb0015","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000185297","article-title":"A case of nephrotic syndrome with glomerular lipoprotein deposition with capillary ballooning and mesangiolysis","volume":"51","author":"Watanabe","year":"1989","journal-title":"Nephron"},{"key":"10.1038\/ki.2013.335_bb0020","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/j.ajkd.2005.10.017","article-title":"Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases","volume":"47","author":"Saito","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2013.335_bb0025","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1053\/j.ajkd.2005.12.031","article-title":"Lipoprotein glomerulopathy: a new apolipoprotein E mutation with enhanced glomerular binding","volume":"47","author":"Sam","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2013.335_bb0030","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1016\/S0021-9258(18)34702-1","article-title":"Human apolipoprotein E. The complete amino acid sequence","volume":"257","author":"Rall","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2013.335_bb0035","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1016\/S0021-9258(18)34954-8","article-title":"Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site","volume":"257","author":"Weisgraber","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2013.335_bb0040","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1681\/ASN.V85820","article-title":"Apolipoprotein E Sendai (arginine 145\u2014>proline): a new variant associated with lipoprotein glomerulopathy","volume":"8","author":"Oikawa","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.335_bb0045","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1046\/j.1523-1755.1999.00572.x","article-title":"A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy","volume":"56","author":"Matsunaga","year":"1999","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.335_bb0050","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000111828","article-title":"Identification of Apolipoprotein E Guangzhou (Arginine 150 Proline), a new variant associated with lipoprotein glomerulopathy","volume":"28","author":"Luo","year":"2008","journal-title":"Am J Nephrol"},{"key":"10.1038\/ki.2013.335_bb0055","first-page":"568","article-title":"A complete genomic analysis of the apolipoprotein E gene in Chinese patients with lipoprotein glomerulopathy","volume":"20","author":"Chen","year":"2007","journal-title":"J Nephrol"},{"key":"10.1038\/ki.2013.335_bb0060","first-page":"110","article-title":"Clinicopathological and genetic characteristics in Chinese patients with lipoprotein glomerulopathy","volume":"21","author":"Zhang","year":"2008","journal-title":"J Nephrol"},{"key":"10.1038\/ki.2013.335_bb0065","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000045513","article-title":"Association of a novel 3-amino acid deletion mutation of apolipoprotein E (Apo E Tokyo) with lipoprotein glomerulopathy","volume":"83","author":"Konishi","year":"1999","journal-title":"Nephron"},{"key":"10.1038\/ki.2013.335_bb0070","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1046\/j.1523-1755.1999.00677.x","article-title":"A novel 18-amino acid deletion in apolipoprotein E associated with lipoprotein glomerulopathy","volume":"56","author":"Ando","year":"1999","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.335_bb0075","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1053\/meta.2002.29990","article-title":"Interaction of endothelial cells and triglyceride-rich lipoproteins with apolipoprotein E (Arg\u2014>Cys) from a patient with lipoprotein glomerulopathy","volume":"51","author":"Murano","year":"2002","journal-title":"Metabolism"},{"key":"10.1038\/ki.2013.335_bb0080","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/jhg.2013.8","article-title":"A founder haplotype of APOE-Sendai mutation associated with lipoprotein glomerulopathy","volume":"58","author":"Toyota","year":"2013","journal-title":"J Hum Genet"},{"key":"10.1038\/ki.2013.335_bb0085","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1053\/j.ajkd.2004.08.048","article-title":"A rare cause of posttransplantation nephrotic syndrome","volume":"45","author":"Foster","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2013.335_bb0090","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1056\/NEJMc072088","article-title":"APOE Kyoto mutation in European Americans with lipoprotein glomerulopathy","volume":"357","author":"Rovin","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2013.335_bb0095","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0021-9150(03)00194-1","article-title":"Disappearance of intraglomerular lipoprotein thrombi and marked improvement of nephrotic syndrome by bezafibrate treatment in a patient with lipoprotein glomerulopathy","volume":"169","author":"Arai","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1038\/ki.2013.335_bb0100","doi-asserted-by":"crossref","first-page":"c260","DOI":"10.1159\/000276578","article-title":"Common apolipoprotein E gene mutations contribute to lipoprotein glomerulopathy in China","volume":"114","author":"Han","year":"2010","journal-title":"Nephron Clin Pract"},{"key":"10.1038\/ki.2013.335_bb0105","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5414\/CN106876","article-title":"A rare cause of childhood-onset nephrotic syndrome: lipoprotein glomerulopathy","volume":"78","author":"Liao","year":"2012","journal-title":"Clin Nephrol"},{"key":"10.1038\/ki.2013.335_bb0110","first-page":"57","article-title":"A rare cause of nephrotic syndrome: lipoprotein glomerulopathy","volume":"15","author":"Cheung","year":"2009","journal-title":"Hong Kong Med J"},{"key":"10.1038\/ki.2013.335_bb0115","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1093\/ndt\/gfs329","article-title":"Macrophage impairment produced by Fc receptor gamma deficiency plays a principal role in the development of lipoprotein glomerulopathy in concert with apoE abnormalities","volume":"27","author":"Ito","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2013.335_bb0120","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10157-011-0554-6","article-title":"Scavenger receptor expressions in the kidneys of mice with lipoprotein glomerulopathy","volume":"16","author":"Miyahara","year":"2011","journal-title":"Clin Exp Nephrol"},{"key":"10.1038\/ki.2013.335_bb0125","doi-asserted-by":"crossref","first-page":"536","DOI":"10.5551\/jat.8102","article-title":"A novel mutation ApoE2 Kurashiki (R158P) in a patient with lipoprotein glomerulopathy","volume":"18","author":"Tokura","year":"2011","journal-title":"J Atheroscler Thromb"},{"key":"10.1038\/ki.2013.335_bb0130","doi-asserted-by":"crossref","first-page":"381","DOI":"10.5301\/JN.2011.7772","article-title":"Lipoprotein glomerulopathy: first report of 2 not consanguineous Italian men from the same town","volume":"24","author":"Pasquariello","year":"2011","journal-title":"J Nephrol"},{"key":"10.1038\/ki.2013.335_bb0135","doi-asserted-by":"crossref","first-page":"531","DOI":"10.5551\/jat.7377","article-title":"A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy","volume":"18","author":"Mitani","year":"2011","journal-title":"J Atheroscler Thromb"},{"key":"10.1038\/ki.2013.335_bb0140","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10157-010-0333-9","article-title":"Successful treatment of lipoprotein glomerulopathy in a daughter and a mother using niceritrol","volume":"14","author":"Hamatani","year":"2010","journal-title":"Clin Exp Nephrol"},{"key":"10.1038\/ki.2013.335_bb0145","doi-asserted-by":"crossref","first-page":"279","DOI":"10.5858\/134.2.279","article-title":"A rare case of lipoprotein glomerulopathy in a white man: an emerging entity in Asia, rare in the white population","volume":"134","author":"Boumendjel","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/ki.2013.335_bb0150","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1093\/ndt\/gfq389","article-title":"A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy","volume":"25","author":"Bomback","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2013.335_bb0155","doi-asserted-by":"crossref","first-page":"9311","DOI":"10.1186\/1752-1947-3-9311","article-title":"Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report","volume":"3","author":"Russi","year":"2009","journal-title":"J Med Case Reports"},{"key":"10.1038\/ki.2013.335_bb0160","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10157-009-0207-1","article-title":"Improvement of nephrotic syndrome by intensive lipid-lowering therapy in a patient with lipoprotein glomerulopathy","volume":"13","author":"Matsunaga","year":"2009","journal-title":"Clin Exp Nephrol"},{"key":"10.1038\/ki.2013.335_bb0165","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/ndt\/gfm675","article-title":"A novel variant apolipoprotein E Okayama in a patient with lipoprotein glomerulopathy","volume":"23","author":"Kinomura","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2013.335_bb0170","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/ndt\/gfm735","article-title":"A novel apolipoprotein E mutation, ApoE Tsukuba (Arg 114 Cys), in lipoprotein glomerulopathy","volume":"23","author":"Hagiwara","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2013.335_bb0175","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/MOL.0b013e328345ebb0","article-title":"Lipoprotein glomerulopathy","volume":"22","author":"Tsimihodimos","year":"2011","journal-title":"Curr Opin Lipidol"},{"key":"10.1038\/ki.2013.335_bb0180","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000045511","article-title":"Lipoprotein glomerulopathy: renal lipidosis induced by novel apolipoprotein E variants","volume":"83","author":"Saito","year":"1999","journal-title":"Nephron"},{"key":"10.1038\/ki.2013.335_bb0185","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/ndt\/gfn555","article-title":"Successful treatment of patients with lipoprotein glomerulopathy by protein A immunoadsorption: a pilot study","volume":"24","author":"Xin","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2013.335_bb0190","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000187897","article-title":"A case of lipoprotein glomerulopathy successfully treated with probucol","volume":"67","author":"Amenomori","year":"1994","journal-title":"Nephron"},{"key":"10.1038\/ki.2013.335_bb0195","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1053\/ajkd.2003.50016","article-title":"Resolution of typical lipoprotein glomerulopathy by intensive lipid-lowering therapy","volume":"41","author":"Ieiri","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2013.335_bb0200","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1126\/science.1217697","article-title":"ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models","volume":"335","author":"Cramer","year":"2012","journal-title":"Science"},{"key":"10.1038\/ki.2013.335_bb0205","doi-asserted-by":"crossref","first-page":"10453","DOI":"10.1074\/jbc.M808482200","article-title":"Peroxisome proliferator-activated receptor {gamma} stimulation of adipocyte ApoE gene transcription mediated by the liver receptor X pathway","volume":"284","author":"Yue","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2013.335_bb0210","first-page":"104","article-title":"Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism","volume":"42","author":"Boerwinkle","year":"1988","journal-title":"Am J Hum Genet"},{"key":"10.1038\/ki.2013.335_bb0215","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000168591","article-title":"Lipoprotein glomerulopathy. Report of a normolipidemic case and review of the literature","volume":"13","author":"Saito","year":"1993","journal-title":"Am J Nephrol"},{"key":"10.1038\/ki.2013.335_bb0220","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0272-6386(12)80649-4","article-title":"Abnormal lipoprotein and apolipoprotein pattern in lipoprotein glomerulopathy","volume":"18","author":"Oikawa","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2013.335_bb0225","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1046\/j.1523-1755.1999.07110.x","article-title":"Lipoprotein glomerulopathy: significance of lipoprotein and ultrastructural features","volume":"71","author":"Saito","year":"1999","journal-title":"Kidney Int Suppl"},{"key":"10.1038\/ki.2013.335_bb0230","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"32","author":"Reiner","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1038\/ki.2013.335_bb0235","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(05)67667-2","article-title":"Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial","volume":"366","author":"Keech","year":"2005","journal-title":"Lancet"},{"key":"10.1038\/ki.2013.335_bb0240","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1159\/000064083","article-title":"Fenofibrate increases creatininemia by increasing metabolic production of creatinine","volume":"92","author":"Hottelart","year":"2002","journal-title":"Nephron"},{"key":"10.1038\/ki.2013.335_bb0245","first-page":"41","article-title":"[Fenofibrate increases blood creatinine, but does not change the glomerular filtration rate in patients with mild renal insufficiency]","volume":"20","author":"Hottelart","year":"1999","journal-title":"Nephrologie"},{"key":"10.1038\/ki.2013.335_bb0250","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/ki.2012.244","article-title":"Proteinuria decreases tissue lipoprotein receptor levels resulting in altered lipoprotein structure and increasing lipid levels","volume":"82","author":"Wang","year":"2012","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.335_bb0255","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0022-2275(20)43176-1","article-title":"Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI","volume":"31","author":"Hixson","year":"1990","journal-title":"J Lipid Res"},{"key":"10.1038\/ki.2013.335_bb0260","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"139","author":"Levey","year":"2003","journal-title":"Ann Intern Med"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815561887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815561887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,6]],"date-time":"2022-03-06T01:03:03Z","timestamp":1646528583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815561887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"alternative-id":["S0085253815561887"],"URL":"https:\/\/doi.org\/10.1038\/ki.2013.335","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}